In the Netherlands, DSM-Firmenich AG has finalized the sale of its yeast extracts business to Lesaffre, a leading global player in fermentation and microorganisms based in Lille, France.
The yeast extracts business, part of DSM-Firmenich’s taste, texture, and health unit, generates approximately €120 million (US$131.7 million) in annual sales. This divestment aligns with the DSM-Firmenich’s strategic decision to deprioritize certain business segments.
As part of the transaction, Lesaffre will supply yeast extracts to DSM-Firmenich for its Savory business until the end of 2025. At that time, yeast extracts production at Delft, the Netherlands will be discontinued.